Suppr超能文献

相似文献

1
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.
J Psychopharmacol. 2016 Dec;30(12):1268-1278. doi: 10.1177/0269881116662634. Epub 2016 Aug 30.
2
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.
J Psychopharmacol. 2016 Dec;30(12):1279-1295. doi: 10.1177/0269881116678781. Epub 2016 Nov 17.
4
Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
J Forensic Sci. 2019 Jul;64(4):1266-1270. doi: 10.1111/1556-4029.13982. Epub 2018 Dec 12.
5
Psilocybin--summary of knowledge and new perspectives.
Eur Neuropsychopharmacol. 2014 Mar;24(3):342-56. doi: 10.1016/j.euroneuro.2013.12.006. Epub 2013 Dec 17.
6
[Automutilation after consumption of hallucinogenic mushrooms].
Ned Tijdschr Geneeskd. 2007 Dec 29;151(52):2869-72.
7
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
J Psychopharmacol. 2011 Nov;25(11):1434-52. doi: 10.1177/0269881110382466. Epub 2010 Sep 20.
8
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
Psychopharmacology (Berl). 2006 Aug;187(3):268-83; discussion 284-92. doi: 10.1007/s00213-006-0457-5. Epub 2006 Jul 7.
9
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.
J Psychopharmacol. 2021 Apr;35(4):437-446. doi: 10.1177/0269881120967878. Epub 2021 Jan 9.
10
Psilocybin: Good Trip or Bad Trip.
Clin Pharmacol Ther. 2017 Oct;102(4):580-584. doi: 10.1002/cpt.697. Epub 2017 May 26.

引用本文的文献

1
Fearful symmetry in altered states: a bi-logic account of psychedelic action.
Front Psychol. 2025 Aug 19;16:1632923. doi: 10.3389/fpsyg.2025.1632923. eCollection 2025.
2
Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.
J Law Med Ethics. 2025 Jul 31;53(2):1-9. doi: 10.1017/jme.2025.10109.
5
Safety pharmacology of acute psilocybin administration in healthy participants.
Neurosci Appl. 2024 Mar 16;3:104060. doi: 10.1016/j.nsa.2024.104060. eCollection 2024.
6
A review of psychedelics trials completed in depression, informed by European regulatory perspectives.
Neurosci Appl. 2025 Feb 26;4:105516. doi: 10.1016/j.nsa.2025.105516. eCollection 2025.
7
Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.
J Psychopharmacol. 2025 Jul 1;39(9):2698811251346697. doi: 10.1177/02698811251346697.
8
The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.
Brain Sci. 2025 May 26;15(6):572. doi: 10.3390/brainsci15060572.
9
Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.
Front Psychol. 2025 Jun 6;16:1580663. doi: 10.3389/fpsyg.2025.1580663. eCollection 2025.
10
Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.
Am J Ophthalmol Case Rep. 2025 Jun 2;39:102359. doi: 10.1016/j.ajoc.2025.102359. eCollection 2025 Sep.

本文引用的文献

1
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.
J Psychopharmacol. 2015 Nov;29(11):1182-90. doi: 10.1177/0269881115609019. Epub 2015 Oct 6.
2
Psilocybin, psychological distress, and suicidality.
J Psychopharmacol. 2015 Sep;29(9):1041-3. doi: 10.1177/0269881115598338.
4
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.
J Psychopharmacol. 2014 Nov;28(11):983-92. doi: 10.1177/0269881114548296. Epub 2014 Sep 11.
5
Psilocybin--summary of knowledge and new perspectives.
Eur Neuropsychopharmacol. 2014 Mar;24(3):342-56. doi: 10.1016/j.euroneuro.2013.12.006. Epub 2013 Dec 17.
6
Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.
J Psychoactive Drugs. 2013 Sep-Oct;45(4):322-8. doi: 10.1080/02791072.2013.825034.
7
Prediction of psilocybin response in healthy volunteers.
PLoS One. 2012;7(2):e30800. doi: 10.1371/journal.pone.0030800. Epub 2012 Feb 17.
8
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
J Psychopharmacol. 2011 Nov;25(11):1453-61. doi: 10.1177/0269881111420188. Epub 2011 Sep 28.
9
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.
Psychopharmacology (Berl). 2011 Dec;218(4):649-65. doi: 10.1007/s00213-011-2358-5. Epub 2011 Jun 15.
10
Harm potential of magic mushroom use: a review.
Regul Toxicol Pharmacol. 2011 Apr;59(3):423-9. doi: 10.1016/j.yrtph.2011.01.006. Epub 2011 Jan 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验